P98-23049-35415
2 vaccinations
4 coded responses
10 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 989 / WA
- Registered
- 2021-01-15
- Relationship
- Self
- Race
- N/A
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-27
Dose 1 — Pfizer-BioNTech
-
2021-01-15
Registered in v-safe
-
2021-01-15
Dose 2 — Pfizer-BioNTech
- 2021-01-15
- 2021-01-15
-
2021-01-16
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Lack of appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-19
Survey response — days 1–6 daily, dose 2MedDRA: Insomnia, Nightmare — Feeling: GoodFree text: Insomnia,nightmaresMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-24
- 2021-01-29
- 2021-02-05
-
2021-02-14
Survey response — day 28, dose 2MedDRA: Hormone level abnormal, Vaginal haemorrhage — Feeling: GoodFree text: Abnormal spotting, hormonal imbalanceMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-18
-
2022-01-15
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: MiscarriagesMedDRA releases: 2024-11 · check-in free text available
-
2022-01-15
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-01-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-27 | Pfizer-BioNTech | |
| 2 | 2021-01-15 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-16 | priority 2/3 | |
| 2022-01-15 | Unsuccessful |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Lack of appetite
Systemic reaction (other): Insomnia,nightmares
Release 4 — day 28, dose 2
Symptoms: Abnormal spotting, hormonal imbalance
Release 10 — 12 months, dose 2
Symptoms: Miscarriages
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Hormone level abnormal | ✓ | ✓ | ✓ |
| SD | Vaginal haemorrhage | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Insomnia | ✓ | ✓ | ✓ |
| SRO | Nightmare | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release